Literature DB >> 3090094

Thyrocyte HLA-DR expression and interferon-gamma production in autoimmune thyroid disease.

Y Iwatani, H C Gerstein, M Iitaka, V V Row, R Volpé.   

Abstract

We examined the expression of HLA-DR antigen induced by mitogen, mitogen-free supernatants from mitogen-stimulated peripheral blood mononuclear cells (PBMC), or autologous and allogeneic PBMC on thyrocytes cultured for 1-2 weeks (precultured) before the addition of the stimulant. Leucoagglutinin (LAG) and concanavalin A, but not lipopolysaccharide induced HLA-DR expression on thyrocytes from normal subjects (NC) and patients with Graves' disease (GD) and Hashimoto's thyroiditis (HT). The degree of DR expression induced by LAG was significantly less in GD than in NC thyrocytes. This response was dependent on contaminating T cells, especially suppressor-cytotoxic T (Ts/c) cells, NK cells, and HLA-DR+ cells, but not helper-inducer T (Th/i) cells or B cells, in the thyrocyte cultures. OKT3 monoclonal antibody, which activates T cells specifically in the presence of monocytes, also induced thyrocyte HLA-DR expression. Furthermore, interferon-gamma (IFN-gamma) was detected in culture supernatants from LAG-stimulated thyrocytes. Anti-IFN-gamma monoclonal antibody eliminated the ability of LAG to induce HLA-DR. Mitogen-free supernatants from mitogen-stimulated PBMC also induced thyrocyte HLA-DR expression, which was inhibited by anti-IFN-gamma. The supernatants of concanavalin A- or LAG-stimulated PBMC from either untreated or recently treated patients with GD or hypothyroid HT induced less thyrocyte DR expression than NC PBMC. Indeed, the levels of IFN-gamma in supernatants from such patients were lower than those in NC, and the correlation between DR expression and IFN-gamma levels was significant. This IFN-gamma production by PBMC required Th/i cells, NK cells, and HLA-DR+ cells. Before the addition of autologous or allogeneic PBMC, only precultured HT thyrocytes expressed HLA-DR, whereas GD and NC thyrocytes did not. The induction or enhancement of DR expression on autologous thyrocytes by direct coculture with PBMC occurred within 8 days in GD and HT, but not in NC. There was a significant correlation between the serum titer of antithyroid microsomal antibodies and the degree of DR expression. Allogeneic normal PBMC also induced DR expression on NC and GD thyrocytes within 8 days, the effect on the latter being more pronounced than with autologous GD PBMC. Thyrocyte HLA-DR expression induced by autologous GD PBMC and allogeneic normal PBMC required monocytes. Th/i, and NK cells and was blocked by anti-IFN-gamma. However, the enhancement of thyrocyte DR expression by autologous HT PBMC did not require monocytes.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090094     DOI: 10.1210/jcem-63-3-695

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

Review 1.  The utility of some modern techniques in understanding thyroid pathology.

Authors:  Virginia A LiVoisi
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

2.  Immunological events leading to destructive thyroiditis in the AUG rat.

Authors:  R Hassman; N Solic; B Jasani; R Hall; A M McGregor
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

3.  Enhanced production of gamma-interferon by thyroid-derived T cell clones from patients with Hashimoto's thyroiditis.

Authors:  G F Del Prete; A Tiri; S Mariotti; A Pinchera; M Ricci; S Romagnani
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

4.  Effects of recombinant human interferon gamma on human thyroid tissues from patients with Graves' disease and normal subjects transplanted into nude mice.

Authors:  Y Kasuga; S Matsubayashi; Y Sakatsume; N Miller; C Jamieson; R Volpé
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

5.  Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic Goiter and in Graves' disease.

Authors:  B Grubeck-Loebenstein; M Londei; C Greenall; K Pirich; H Kassal; W Waldhäusl; M Feldmann
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

6.  Induction of HLA-DR expression on thyroid follicular cells by cytomegalovirus infection in vitro. Evidence for a dual mechanism of induction.

Authors:  E L Khoury; L Pereira; F S Greenspan
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

7.  CD4 cells from patients with autoimmune thyroid disease secrete interferon gamma after stimulation by thyroid microsomal antigen; CD8 cells suppress this secretion.

Authors:  Y Sakatsume; S Matsubayashi; Y Kasuga; M Iitaka; Y Iwatani; R Volpé
Journal:  J Endocrinol Invest       Date:  1990-10       Impact factor: 4.256

8.  Expression of HLA-DR antigens in inflammatory bowel disease mucosa: role of intestinal lamina propria mononuclear cell-derived interferon gamma.

Authors:  O Y Qin; M el-Youssef; B Yen-Lieberman; W Sapatnekar; K R Youngman; K Kusugami; C Fiocchi
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

9.  Expression of vascular adhesion molecules on human endothelia in autoimmune thyroid disorders.

Authors:  M Marazuela; F Sánchez-Madrid; A Acevedo; E Larrañaga; M O de Landázuri
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

10.  In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.

Authors:  S Matsubayashi; F Akasu; Y Kasuga; K Snow; E Keystone; R Volpé
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.